TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
PBYI

Puma Biotechnology, Inc.

Healthcare · Biotechnology

10.00$ +1.6% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Puma Biotechnology, Inc. (PBYI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 193 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PBYI
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
134 253 217 173 182 166 170 228 231 259 331 240 232 235 226 264 262 244 259 260 226 227 201 194 199 222 196 200 204 231 214 205 221 213 196 195 203 216 193 193
117 236 205 161 120 106 111 170 174 203 256 158 151 166 159 159 160 146 164 168 137 140 118 114 122 134 112 119 125 156 143 138 157 148 133 137 144 163 142 145
53 195 105 81 80 82 79 96 68 108 49 27 59 60 83 91 90 85 96 90 64 63 64 53 78 76 61 60 82 85 77 67 67 69 63 55 54 30 36 37
109 195 194 152 106 82 79 135 68 108 49 118 59 112 101 107 109 93 109 109 88 82 74 61 78 81 71 74 85 96 107 97 97 101 93 96 94 98 102 94
1.2 – – – 3.9 9.7 16 21 31 22 91 25 27 29 32 24 27 26 26 31 24 33 27 34 32 42 31 31 29 48 25 28 55 32 25 26 34 54 26 34
0.0 0.0 0.0 0.0 0.1 2.0 2.7 2.5 2.8 2.6 2.6 3.3 3.1 3.2 3.3 2.9 3.1 3.5 7.7 7.6 7.2 7.1 7.3 6.7 5.5 4.5 3.9 7.6 5.7 7.1 7.1 9.0 2.7 8.7 8.8 8.6 9.5 5.5 8.7 13
5.2 5.2 5.0 4.9 4.7 4.5 4.3 4.3 4.2 4.0 3.7 3.4 3.2 3.3 3.1 2.9 2.7 2.5 2.3 17 1.9 16 1.6 1.4 1.3 1.1 1.0 1.0 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 49 48 47 46 45 44 43 42 41 40 39 78 76 74 72 70 68 66 64 62 60 71 68 66 63 61 58 56 54 51 49 46 44 41 39 37
43 43 49 53 103 112 112 189 185 225 288 218 215 217 216 240 262 250 242 231 237 229 194 174 177 200 170 170 165 177 163 156 150 121 99 90 88 86 64 54
38 37 44 47 97 58 58 64 58 67 101 92 88 91 90 95 118 114 140 138 116 110 75 57 60 77 48 60 67 99 98 104 110 96 87 79 83 81 60 50
– – – – – 48 49 120 – – 2.2 2.3 2.5 2.6 2.7 2.9 8.7 17 26 35 3.5 3.6 3.7 3.8 4.0 4.1 4.3 16 27 39 50 50 51 51 51 38 36 24 11 0.5
21 20 24 25 18 28 24 22 16 21 29 15 9.1 19 17 12 13 12 11 11 20 11 7.4 9.8 15 6.4 8.6 7.8 5.1 6.9 9.0 14 7.5 5.5 6.0 5.4 6.4 5.1 8.2 3.1
0.0 0.0 0.0 0.0 0.0 48 49 120 121 152 153 93 94 95 96 97 92 84 76 69 97 97 97 98 98 98 99 88 77 66 55 44 33 22 11 11 – – – –
91 210 167 120 79 53 57 38 46 34 44 22 17 17 9.4 23 -0.5 -6.0 16 29 -11 -2.4 7.1 20 22 22 26 30 39 53 51 49 71 92 97 105 115 130 128 139
-724 -797 -869 -947 -1,024 -1,088 -1,113 -1,157 -1,171 -1,202 -1,212 -1,250 -1,266 -1,278 -1,295 -1,291 -1,323 -1,338 -1,321 -1,326 -1,371 -1,367 -1,370 -1,361 -1,361 -1,367 -1,365 -1,363 -1,357 -1,345 -1,350 -1,355 -1,334 -1,315 -1,312 -1,306 -1,297 -1,284 -1,288 -1,279
32 36 37 37 37 38 38 38 38 38 38 39 39 39 39 40 40 40 41 40 41 41 42 45 46 46 47 47 48 48 48 48 49 49 50 50 51 52 51 53

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?